Pharmacovigilance of artemether-lumefantrine in pregnant women followed until delivery in Rwanda.
about
First-trimester artemisinin derivatives and quinine treatments and the risk of adverse pregnancy outcomes in Africa and Asia: A meta-analysis of observational studiesMalaria: an update on current chemotherapy.Treating severe malaria in pregnancy: a review of the evidenceThe Safety of Artemisinin Derivatives for the Treatment of Malaria in the 2nd or 3rd Trimester of Pregnancy: A Systematic Review and Meta-Analysis.Risks of miscarriage and inadvertent exposure to artemisinin derivatives in the first trimester of pregnancy: a prospective cohort study in western KenyaAssessment of the safety of antimalarial drug use during early pregnancy (ASAP): protocol for a multicenter prospective cohort study in Burkina Faso, Kenya and Mozambique.Safety of artemisinins in first trimester of prospectively followed pregnancies: an observational study.Use of artemether-lumefantrine to treat malaria during pregnancy: what do we know and need to know?Methodology of assessment and reporting of safety in anti-malarial treatment efficacy studies of uncomplicated falciparum malaria in pregnancy: a systematic literature review.Systematic literature review and meta-analysis of the efficacy of artemisinin-based and quinine-based treatments for uncomplicated falciparum malaria in pregnancy: methodological challenges.Population pharmacokinetics of artemether, dihydroartemisinin and lumefantrine in Rwandese pregnant women treated for uncomplicated malariaImproved safety margin for embryotoxicity in rats for the new endoperoxide artefenomel (OZ439) as compared to artesunateAnimal Embryotoxicity Studies of Key Non-Artemisinin Antimalarials and Use in Women in the First Trimester
P2860
Q33626397-03665C5C-3011-4461-92A2-029A2D15369FQ34433106-FC161E82-5BD6-4819-9984-36C62CB7F8E0Q34456393-B3D04375-E7FB-4A4A-9FC1-88910787658CQ36185610-40C0547A-E7AF-4DD3-AFD1-2B5AC4EB4B59Q36298460-B381BDF4-D667-49A4-AA9E-FEE7F1BC7F46Q36348696-6CD7B037-51B2-4DA3-A192-51C0FDC20949Q36809595-D04C9707-AA2C-4A5A-AFAC-665E29292208Q42712939-87870A26-A361-4ECE-A82C-E602D47AD8DBQ47158581-70E527BE-CFC8-42B9-9FFF-2B7AF4CB59C3Q47244112-82430B06-BEEB-4758-B13B-E9CC43AE2559Q56354961-46EB9259-C33E-4027-8A24-9D9D1424B057Q56384056-10B84E4F-4840-45B0-93A5-E8F3C37854BBQ56428696-48FD8442-2A47-465D-9AEB-5F9157BB60E3
P2860
Pharmacovigilance of artemether-lumefantrine in pregnant women followed until delivery in Rwanda.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Pharmacovigilance of artemethe ...... owed until delivery in Rwanda.
@ast
Pharmacovigilance of artemethe ...... owed until delivery in Rwanda.
@en
type
label
Pharmacovigilance of artemethe ...... owed until delivery in Rwanda.
@ast
Pharmacovigilance of artemethe ...... owed until delivery in Rwanda.
@en
prefLabel
Pharmacovigilance of artemethe ...... owed until delivery in Rwanda.
@ast
Pharmacovigilance of artemethe ...... owed until delivery in Rwanda.
@en
P2093
P2860
P356
P1433
P1476
Pharmacovigilance of artemethe ...... owed until delivery in Rwanda.
@en
P2093
Corine Karema
Nadine Kaligirwa
Peter J de Vries
Petra F Mens
Steven Agaba
P2860
P2888
P356
10.1186/1475-2875-11-225
P577
2012-07-06T00:00:00Z
P5875
P6179
1026298944